Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SPRY compared with MLYS: revenue, margins and what each company keeps, and the suppliers and customers both name
SPRY
ARS Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
MLYS
Mineralys Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SPRY
ARS Pharmaceuticals, Inc.
vs
MLYS
Mineralys Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
SPRY
with
MLYS
Uncorrelated: r 0.09 · 500D.
Shared co-movers
1
with SPRY
with MLYS
INFQ
Infleqtion, Inc.
r 0.28
r 0.31
SPRY, solid
MLYS, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
SPRY
ARS Pharmaceuticals, Inc.
Change
3.04
▼
−0.49%
· post 3.06
Mkt cap
$303.3M
Revenue
$34M
Q2 FY26
Revenue
$84M
FY25
MLYS
Mineralys Therapeutics, Inc.
Change
17.00
▲
+6.32%
· post 16.80
Closed
Nov 4 '26
Mkt cap
$1.4B
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 4 '26
SPRY
ARS Pharmaceuticals, Inc.
vs
MLYS
Mineralys Therapeutics, Inc.
3.04
▼
−0.49%
post 3.06
Price
17.00
▲
+6.32%
post 16.80
$303.3M
Mkt cap
$1.4B
Q2 FY26
$34M
Revenue
—
FY25
$84M
Revenue
—
Change
Change
SPRY
3.04
▼
−0.49%
vs
MLYS
17.00
▲
+6.32%
Closed
Nov 4 '26